Two psychiatrists published a 2025 report documenting significant improvement in depression and anxiety symptoms in two patients who started tirzepatide: The first patient was a 36-year-old with major depressive disorder, generalized anxiety disorder, and binge-eating disorder
Immune support: choose an immune-focused blend with well-known botanical and nutrient support
If there is no significant alleviation of symptoms after a few days, it may be necessary to consult your healthcare provider for further evaluation or modification of treatment
While GLP-1 medication prices are gradually coming down and availability is improving, these treatments remain frustratingly out of reach for many families who could benefit from them
However, GLP-1 medications are not a substitute for healthy habits
Weve been dispensing GLP-1s since 2021 and have continued to expand access to treatments like Eli Lilly and Company's Zepbound and Novo Nordisk's Wegovy and more
